A study published in the journal Diagnostic Microbiology and Infectious Disease addresses the observed negative effects of the COVID-19 pandemic on the timely diagnosis of tick-borne infections (TBD) in three adult patients.
Promising Dapsone Research/WG Meeting: Access to Care Under Attack/CDC Announces Nat’l Framework/Researchers ID Bat Tick in NJ/NIH Grants $1.9M for Lyme Vaccine/Lyme & Pregnancy Study/Oct 27 Next TBDWG Mtg
Dr. Richard Horowitz et al. just published a new in vitro study on dapsone (diaminodiphenyl sulfone) and dapsone combination therapy (DDS CT). The study is suggestive that dapsone combination therapy may well characterize both a novel and successful option to treat Borrelia burgdorferi “persister” cells, which are the biofilm form of the bacteria.
The issue of Lyme disease and pregnancy is a serious one, and much more research and education is needed to understand the extent and scope of the problems related to pregnancy and Lyme. The Lyme Disease Association (LDA) is providing information on a study on Lyme and Pregnancy which is led by researchers from the […]
First announced at the HHS Tick-Borne Disease Working Group’s (TBDWG) September 22 meeting, the Centers for Disease Control (CDC), in a Capitol Hill Announcement, presented plans to join with five federal departments and the Environmental Protection Agency in developing the National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans (Framework). […]
In a recent Rutgers University-led study, researchers identified Carios kelleyi, a “soft” tick species associated with bats, for the first time in New Jersey. This parasite, of almost exclusively bats, is thought widespread in the US (as well as parts of Canada, Mexico, Costa Rica, and Cuba), with known occurrences in 29 of the 48 […]
West Virginia University researchers received a $1.9 million grant from the National Institute of Allergy and Infectious Diseases, an institution of the National Institute of Health (NIH), for a vaccine to prevent humans from contracting Lyme disease. Mariette Barbier, assistant professor in the School of Medicine’s Department of Microbiology, Immunology and Cell Biology, is leading […]
Speak up on Chronic Lyme in WG/Lyme in Insurance Plan/New Repellent Ingredient/Tick Virus Outbreak in China/LDA-Approved Nat’l. Charity/Increased $$-Lyme Amendment/TBD in Fleas/NIH Awards Vaccine $$/Lyme-Dementia
The upcoming meeting of the HHS Working Group may be your last chance to influence language on persistent/chronic Lyme. At the last meeting, several members of the Working Group (WG) worked hard to have language related to patients with persistent Lyme symptoms removed from the WG report which will go to Congress at end of year.
The upcoming meeting of the HHS Working Group on Sept. 15 may be your last chance to influence language on persistent/chronic Lyme. At the last meeting, several members of the Working Group (WG) worked hard to have language related to patients with persistent Lyme symptoms removed from the WG report which will go to Congress at end of year.
With a new $3.5 million grant from the National Institutes of Health (NIH), Utpal Pal, PhD, professor in Veterinary Medicine at the University of Maryland (UMD) will be partnering with Matthias Schnell, director of the Jefferson Vaccine Center at Thomas Jefferson University to develop a novel “next-generation” Lyme disease vaccine. Pal, a tick immunobiologist, and […]
American insurer Colonial Life is offering a new critical illness plan with optional rider that offers a lump sum benefit for hospitalization for treatment of COVID-19 and over 12 other infectious diseases, such as Lyme disease, antibiotic-resistant bacteria, Legionnaires’ disease, meningitis, and sepsis. For the critical illness plan’s Lyme disease coverage: the date of Lyme […]